$1.290
0.000 (0.00%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
SNOA Prediction & Forecast by Similar Chart Analysis
Alphio's SNOA stock price prediction model matches the current Sonoma Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.29 (+0.23%). The 1-week path is $1.28 (-1.04%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Sonoma Pharmaceuticals Inc Stock?
Sonoma Pharmaceuticals Inc (SNOA) is currently trading at $1.31 with a forward P/E ratio of 46.08, indicating high future earnings expectations despite recent losses. The stock has a current RSI of 43.68, suggesting it is nearing oversold territory, but the year-to-date change of -64.01% raises concerns about its long-term viability. The recent FDA clearance for its Microdacyn product could drive future growth, but the significant net losses, including a net loss of $581,000 in Q4 2026, present a risk that investors should consider before buying.
SNOA stock price ended at $1.29 on Tuesday, after rising 0.00%
Sonoma Pharmaceuticals Inc (SNOA) last closed at $1.29, gaining +0.00%. These facts feed the 1-day and 1-week SNOA price prediction above.
Analyst Consensus
Sonoma Pharmaceuticals Inc (SNOA): 2 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Sonoma Pharmaceuticals Inc (SNOA) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bearish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches SNOA, ranked by similarity.
Seasonality analysis for SNOA
Historically the probability of a positive September return for SNOA is 59.52%. July offers the highest probability of a positive month at 66.67%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for SNOA
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Sep 2026 | $3.03 | $3.34 | $3.67 | +158.77% |
| Oct 2026 | $3.71 | $4.46 | $5.24 | +246.02% |
| Nov 2026 | $3.30 | $3.86 | $4.03 | +199.61% |
| Dec 2026 | $3.78 | $4.08 | $4.90 | +216.48% |
In 2026, Sonoma Pharmaceuticals Inc (SNOA) is projected to range from $3.03 to $5.24.
Sonoma Pharmaceuticals Inc 2026 monthly forecast
In Sep 2026, Sonoma Pharmaceuticals Inc is projected to average $3.34, with a low of $3.03 and high of $3.67.
In Oct 2026, Sonoma Pharmaceuticals Inc is projected to average $4.46, with a low of $3.71 and high of $5.24.
In Nov 2026, Sonoma Pharmaceuticals Inc is projected to average $3.86, with a low of $3.30 and high of $4.03.
In Dec 2026, Sonoma Pharmaceuticals Inc is projected to average $4.08, with a low of $3.78 and high of $4.90.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.